XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Income Tax Expense
12 Months Ended
Sep. 30, 2023
Income Tax Expense  
Income Tax Expense

5.      Income Tax Expense

The components of income before income taxes for 2023, 2022 and 2021 consisted of the following:

(Dollars in thousands)

    

2023

    

2022

    

2021

United States

$

98,983

 

90,674

 

70,214

Foreign

 

19,964

 

15,761

 

10,457

Total income before income taxes

$

118,947

 

106,435

 

80,671

The principal components of income tax expense (benefit) for 2023, 2022 and 2021 consist of:

(Dollars in thousands)

    

2023

    

2022

    

2021

Federal:

 

  

 

  

 

  

Current

$

24,192

 

7,248

 

14,807

Deferred

 

(5,816)

 

9,752

 

(1,598)

State and local:

 

 

 

Current

 

3,563

 

1,635

 

2,257

Deferred

 

(1,038)

 

1,774

 

(786)

Foreign:

 

 

 

Current

 

5,694

 

4,645

 

2,922

Deferred

 

(193)

 

(939)

 

(427)

Total

$

26,402

 

24,115

 

17,175

The actual income tax expense for 2023, 2022 and 2021 differs from the expected tax expense for those years (computed by applying the U.S. Federal corporate statutory rate) as follows:

    

2023

    

2022

    

2021

 

Federal corporate statutory rate

    

21.0

%  

21.0

%  

21.0

%

State and local, net of Federal benefits

2.1

 

2.9

 

1.9

Impact of foreign operations

0.3

(0.3)

(0.4)

Federal research credit

(1.1)

(0.3)

(0.9)

Executive compensation

0.9

 

0.5

 

0.9

Valuation allowance

0.3

 

(0.3)

 

U.S. tax on GILTI

1.2

1.8

1.0

GILTI foreign tax credits

(0.9)

(1.5)

(0.6)

FDII deduction

(1.6)

(0.9)

(1.7)

Other, net

 

(0.2)

 

0.1

Effective income tax rate

22.2

%  

22.7

%  

21.3

%

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at September 30, 2023 and 2022 are presented below:

(Dollars in thousands)

    

2023

    

2022

Deferred tax assets:

 

  

 

  

Inventories

$

5,457

 

4,990

Pension and other postretirement benefits

 

658

 

664

Capitalized research and development expenditures

4,114

Lease liabilities

9,822

7,073

Net operating and capital loss carryforwards — domestic

 

553

 

575

Net operating loss carryforward — foreign

 

3,714

 

3,396

Other compensation-related costs and other cost accruals

 

8,691

 

9,093

State credit carryforward

 

2,249

 

1,676

Foreign credit carryforward

203

Total deferred tax assets

 

35,258

 

27,670

 

 

Deferred tax liabilities:

 

 

ROU assets

(9,822)

(7,073)

Goodwill

 

(13,313)

 

(11,691)

Acquisition intangible assets

 

(61,187)

 

(62,051)

Depreciation, software amortization

 

(21,772)

 

(24,503)

Net deferred tax liabilities before valuation allowance

 

(70,836)

 

(77,648)

Less valuation allowance

 

(1,772)

 

(1,208)

Net deferred tax liabilities

$

(72,608)

 

(78,856)

We had a foreign net operating loss (NOL) carryforward of $13.2 million at September 30, 2023, which reflects tax loss carryforwards in Germany, South Africa, Canada, Japan, India and the United Kingdom. Approximately $11.1 million of the tax loss carryforwards have no expiration date while the remaining $2.1 million will expire between 2030 and 2042.We had deferred tax assets related to state NOL carryforwards of $0.6 million at September 30, 2023 which expire between 2025 and 2043. We also had state research and other credit carryforwards of $2.2 million of which $0.8 million expires between 2036 and 2038. The remaining $1.4 million does not have an expiration date.

The valuation allowance for deferred tax assets as of September 30, 2023 and 2022 was $1.8 million and $1.2 million, respectively. The net change in the total valuation allowance for each of the years ended September 30, 2023 and 2022 was an increase of $0.6 million and a decrease of $0.8 million, respectively. In addition, we maintained a valuation allowance against state NOL carryforwards that are not expected to be realized in future periods of $0.5 million at September 30 of both 2023 and 2022. Lastly, we recorded a valuation allowance against foreign deferred tax assets of $0.6 million in the year ended September 30, 2023, which resulted in a valuation allowance against foreign deferred assets which may not be realized in future periods of $1.3 million and $0.7 million at September 30, 2023 and 2022, respectively.

As of September 30, 2023, the Company does not have any material unrecognized tax benefits.